UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes Journal article
Zhang Cheng, Yanbo Yuan, Xue Han, Shangli Cai, Fude Yang, Zheng Lu, Chuanyue Wang, Hong Deng, Jingping Zhao, Yutao Xiang, Christoph U Correll, Xin Yu. An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33(10), 1227-1236.
Authors:  Zhang Cheng;  Yanbo Yuan;  Xue Han;  Shangli Cai;  Fude Yang; et al.
Favorite | TC[WOS]:25 TC[Scopus]:25  IF:4.5/4.5 | Submit date:2020/05/26
First-episode  Schizophrenia  Antipsychotic  Efficacy  Safety  
Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial Journal article
Cheng Zhang, Yuan Yanbo, Han Xue, Yang Lei, Zeng Xin, Yang Fude, Lu Zheng, Wang Chuanyue, Deng Hong, Zhao Jingping, Xiang Yu-Tao, Christoph U. Correll, Yu Xin. Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial[J]. Psychiatry Research, 2019, 273, 631-640.
Authors:  Cheng Zhang;  Yuan Yanbo;  Han Xue;  Yang Lei;  Zeng Xin; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:4.2/5.3 | Submit date:2020/09/25
First-episode  Antipsychotic  Discontinuation  Predictors  Schizophrenia